A nurse is meeting with a new client at a substance use disorder clinic. During the meeting, the client states that they have been using cocaine at least once daily for the past 6 months. The nurse is collecting which of the following types of data from the client's account?

A. Stimulants: While stimulants can cause symptoms such as increased energy, agitation, and paranoia, the specific combination of paranoia, visual disturbances (such as talking to the wall), and altered perception is more indicative of hallucinogen use.
B. Anabolic steroids: Anabolic steroids primarily affect physical strength and body composition, and while they can lead to aggressive behavior, they do not typically cause the acute symptoms of paranoia and visual hallucinations seen in this client.
C. Hallucinogens: The symptoms described, including paranoia, dizziness, vomiting, and visual disturbances (evidenced by the client talking to the wall), are characteristic of hallucinogen use. Hallucinogens can induce altered perceptions and significant changes in mood and thought processes, leading to behaviors like the ones exhibited by the client.
D. Opioids: Opioids generally cause sedation, respiratory depression, and a sense of euphoria, but they do not typically produce paranoia or hallucinations. The symptoms presented by the client do not align with opioid intoxication.

A. Biologic parent with schizophrenia: Having a biological parent with schizophrenia significantly increases an individual's risk of developing the disorder due to genetic and hereditary factors. Family studies have shown that the risk of schizophrenia is higher among first-degree relatives, indicating a strong genetic component.
B. Biologic grandparent with fragile X syndrome: Fragile X syndrome is a genetic disorder associated with intellectual disability but is not directly related to the risk of developing schizophrenia. While genetic factors can play a role in various mental health disorders, fragile X syndrome does not specifically indicate an increased risk for schizophrenia.
C. Biologic uncle with Rett syndrome: Rett syndrome is a neurological disorder that primarily affects females and is not associated with an increased risk of schizophrenia. The genetic risk for schizophrenia is more relevant among immediate family members rather than extended relatives like uncles.
D. Biologic sibling with Down syndrome: Down syndrome is a chromosomal disorder caused by an extra copy of chromosome 21 and does not directly increase the risk of developing schizophrenia. While individuals with Down syndrome may experience other mental health issues, the genetic risk for schizophrenia is not associated with this condition.